HIV Co-Receptor Usage, Broadly Neutralising Antibodies, and Treatment
The discovery of a new generation of highly potent broadly neutralising antibodies (bnAb) has provided a new weapon in the fight against HIV-1. It is envisioned that multiple bnAb or a single bnAb in conjunction with antiretrovirals (ARV) can be used to treat HIV infection, especially individuals ha...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2019-07-01
|
Series: | European Medical Journal Allergy & Immunology |
Subjects: | |
Online Access: | https://www.emjreviews.com/allergy-immunology/article/hiv-co-receptor-usage-broadly-neutralising-antibodies-and-treatment/ |